pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-100 |
Genomic Coordinates | chr11: 122152229 - 122152308 |
Synonyms | MIRN100, miR-100, MIR100 |
Description | Homo sapiens miR-100 stem-loop |
Comment | This sequence is localised to chromosome 11 and was named mir-100-11 in reference . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-100-3p | |||||||||||||||||||||||||||
Sequence | 48| CAAGCUUGUAUCUAUAGGUAUG |69 | |||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||
Experiments | Cloned | |||||||||||||||||||||||||||
Editing Events in miRNAs |
|
|||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ABCB5 | ||||||||||||||||||||
Synonyms | ABCB5alpha, ABCB5beta, EST422562 | ||||||||||||||||||||
Description | ATP binding cassette subfamily B member 5 | ||||||||||||||||||||
Transcript | NM_001163941 | ||||||||||||||||||||
Other Transcripts | NM_001163942 , NM_001163993 , NM_178559 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on ABCB5 | |||||||||||||||||||||
3'UTR of ABCB5 (miRNA target sites are highlighted) |
>ABCB5|NM_001163941|3'UTR 1 TGCTGTTGAGGTAGCACATATTTTGATGTTCGTGTAATGCAAAGAAGGAGTACTTAATAATTACTTGGCAAGCTTTGATC 81 TCTTTTATTGCATATATCAATACCTAGAATCATGCTACTCAAGTACATACATGTTCTATTCACACACCATCTGACCTTCA 161 GATTTTTAAAAGGAAGCAAAAATTTGCTTATTTCATGTAAGTGAAATAATGCTTATATCCTTCACTTTATAAAACTATTC 241 TAGCACATTTGCTTGTAAAGCAGTTTTCTACAAGGTGAATTTATTTCCCATCAACTTCTGCTATAAAATCGGAAATATGT 321 TTCCAGGGGGAATATTATCCAATTAACCATGTTGAAGGTTTTAGCAAAGGCAGTGTAAGATAGAGTGGGGCCTGTAGCAT 401 TGCAGGGAGAGTGTCTTTCACTTGGAATTTTGTTTTGCAGCACATATTACAGTAGTTTTGCTAGTCCCTTTTCTCCAGAC 481 CGTAGGGATTTCTCTCAATAAGTATTCACTATTTCTCTAAATTTTATTCTATTTTTTTGTTGAGCAGGGAATAGAAAGGA 561 TTACGATGTAAAATTTCTGGGAGGATTAGGTAGCTATCTCCTACTTCACCAGTAAGTGAAGTGCCTCACATGAGCCATCC 641 CAAAGATTCATTATTCCAAACCTTGGGTTTGGCAGTATAAGTCACAGGCCTACCTGTTTATGAAAACTTACTTACTTAAA 721 ATAAGAGCTACTTTTGGGCCGGGTGCGGTGGCTCACGCCTGTAATCCCAGAACTTTGGGAGGCCGAGGAGGGCGGATCAC 801 TTGAGGTCAGGAGTTCGAGACCAGCCTGGCCAACATGGTGAAACCCCGTCTCTACTAAAAACACAAAAATTAGCCAATCT 881 TGGTGGCGGGCACCTGGAATCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATCATTTGAACCTAGGAGGCAGAGGTTGCA 961 GTGAGCCGAGATCTCACCACTGCACTCCAGCCTGCGCAACAGAGCGAGACTCCATCTCAAAAAATAATAAATAAGAGCTA 1041 ATTTTATTGTGGGTGAAAATTTTTAAACGTCTTTCTCTATAATAAAATAATTTCCTTAAATTTTATATATACTTTATCAT 1121 ATATAATGTGTGAATGATTTTAAAGTTCTGTGTAAATAACAATATTGGTAAAATGAGTTACATTTTCAACTTACTTAAAT 1201 ATGTAATGTCACCTGGTGATTTTATCTTTATTCTTCAGTGTATTTTCTTCCATTTACACATTTAGCTAGCCTCCCTAAAG 1281 TGTACTCTACCAATAATTGAAATCTTGTTAAACAAAATTAAAACCATTTATATATTATGCTGCTTTCTTTAAAATGCAAA 1361 ATAAAAATAAGATTGGGGACTTGAGAATCA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | BC-3 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM796039. RNA binding protein: AGO2. Condition:4-Thiouridine
PAR-CLIP data was present in GSM796040. RNA binding protein: AGO2. Condition:4-Thiouridine
... - Gottwein E; Corcoran DL; Mukherjee N; et al., 2011, Cell host & microbe. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Gottwein E; Corcoran DL; Mukherjee N; et al. - Cell host & microbe, 2011
Primary effusion lymphoma (PEL) is caused by Kaposi's sarcoma-associated herpesvirus (KSHV) and frequently also harbors Epstein-Barr virus (EBV). The expression of KSHV- and EBV-encoded microRNAs (miRNAs) in PELs suggests a role for these miRNAs in latency and lymphomagenesis. Using PAR-CLIP, a technology which allows the direct and transcriptome-wide identification of miRNA targets, we delineate the target sites for all viral and cellular miRNAs expressed in PEL cell lines. The resulting data set revealed that KSHV miRNAs directly target more than 2000 cellular mRNAs, including many involved in pathways relevant to KSHV pathogenesis. Moreover, 58% of these mRNAs are also targeted by EBV miRNAs, via distinct binding sites. In addition to a known viral analog of cellular miR-155, we show that KSHV encodes a viral miRNA that mimics cellular miR-142-3p function. In summary, this study identifies an extensive list of KSHV miRNA targets, which are likely to influence viral replication and pathogenesis.
LinkOut: [PMID: 22100165]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | EF3D-AGO2 , LCL-BAC |
Disease | MIMAT0004512 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1020021. RNA binding protein: AGO2. Condition:EBV B95-8-infected
"PAR-CLIP data was present in GSM1020023. RNA binding protein: AGO2. Condition:EBV B95-8-infected
... - Skalsky RL; Corcoran DL; Gottwein E; Frank et al., 2012, PLoS pathogens. |
Article |
- Skalsky RL; Corcoran DL; Gottwein E; Frank et al. - PLoS pathogens, 2012
Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus linked to a number of B cell cancers and lymphoproliferative disorders. During latent infection, EBV expresses 25 viral pre-microRNAs (miRNAs) and induces the expression of specific host miRNAs, such as miR-155 and miR-21, which potentially play a role in viral oncogenesis. To date, only a limited number of EBV miRNA targets have been identified; thus, the role of EBV miRNAs in viral pathogenesis and/or lymphomagenesis is not well defined. Here, we used photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) combined with deep sequencing and computational analysis to comprehensively examine the viral and cellular miRNA targetome in EBV strain B95-8-infected lymphoblastoid cell lines (LCLs). We identified 7,827 miRNA-interaction sites in 3,492 cellular 3'UTRs. 531 of these sites contained seed matches to viral miRNAs. 24 PAR-CLIP-identified miRNA:3'UTR interactions were confirmed by reporter assays. Our results reveal that EBV miRNAs predominantly target cellular transcripts during latent infection, thereby manipulating the host environment. Furthermore, targets of EBV miRNAs are involved in multiple cellular processes that are directly relevant to viral infection, including innate immunity, cell survival, and cell proliferation. Finally, we present evidence that myc-regulated host miRNAs from the miR-17/92 cluster can regulate latent viral gene expression. This comprehensive survey of the miRNA targetome in EBV-infected B cells represents a key step towards defining the functions of EBV-encoded miRNAs, and potentially, identifying novel therapeutic targets for EBV-associated malignancies.
LinkOut: [PMID: 22291592]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | LCL-BAC-D2 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1133252. RNA binding protein: AGO2. Condition:Untreated
... - Majoros WH; Lekprasert P; Mukherjee N; et al., 2013, Nature methods. |
Article |
- Majoros WH; Lekprasert P; Mukherjee N; et al. - Nature methods, 2013
High-throughput sequencing has opened numerous possibilities for the identification of regulatory RNA-binding events. Cross-linking and immunoprecipitation of Argonaute proteins can pinpoint a microRNA (miRNA) target site within tens of bases but leaves the identity of the miRNA unresolved. A flexible computational framework, microMUMMIE, integrates sequence with cross-linking features and reliably identifies the miRNA family involved in each binding event. It considerably outperforms sequence-only approaches and quantifies the prevalence of noncanonical binding modes.
LinkOut: [PMID: 23708386]
|
CLIP-seq Support 1 for dataset GSM1020021 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | EF3D-AGO2 / EBV B95-8-infected, 4-thiouridine, RNase T1 |
Location of target site | ENST00000404938.2 | 3UTR | UUGGCAAGCUUUGAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22291592 / GSE41437 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1020023 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | LCL-BAC / EBV B95-8-infected, 4-thiouridine, RNase T1 |
Location of target site | ENST00000404938.2 | 3UTR | UUGGCAAGCUUUGAUCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22291592 / GSE41437 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM1133252 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | LCL-BAC-D2 / Untreated |
Location of target site | ENST00000404938.2 | 3UTR | UUGGCAAGCUUUGAUCUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23708386 / GSE46611 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM796039 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-3 / 4-Thiouridine |
Location of target site | ENST00000404938.2 | 3UTR | UUGGCAAGCUUUGAUCUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM796040 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-3 / 4-Thiouridine |
Location of target site | ENST00000404938.2 | 3UTR | UUGGCAAGCUUUGAUCUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
107 hsa-miR-100-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT105690 | LEPROTL1 | leptin receptor overlapping transcript like 1 | 2 | 2 | ||||||||
MIRT151558 | HNRNPUL1 | heterogeneous nuclear ribonucleoprotein U like 1 | 2 | 4 | ||||||||
MIRT167753 | SGK1 | serum/glucocorticoid regulated kinase 1 | 2 | 2 | ||||||||
MIRT195380 | CBFB | core-binding factor beta subunit | 2 | 2 | ||||||||
MIRT283995 | DNAJA2 | DnaJ heat shock protein family (Hsp40) member A2 | 2 | 2 | ||||||||
MIRT317145 | E2F3 | E2F transcription factor 3 | 2 | 4 | ||||||||
MIRT380785 | ZFP3 | ZFP3 zinc finger protein | 2 | 2 | ||||||||
MIRT380927 | ZNF264 | zinc finger protein 264 | 2 | 2 | ||||||||
MIRT441600 | ABCB5 | ATP binding cassette subfamily B member 5 | 2 | 6 | ||||||||
MIRT443896 | NUDT3 | nudix hydrolase 3 | 2 | 4 | ||||||||
MIRT444030 | GREM1 | gremlin 1, DAN family BMP antagonist | 2 | 4 | ||||||||
MIRT444112 | CEPT1 | choline/ethanolamine phosphotransferase 1 | 2 | 2 | ||||||||
MIRT444169 | ZNF701 | zinc finger protein 701 | 2 | 2 | ||||||||
MIRT444366 | TIMM8B | translocase of inner mitochondrial membrane 8 homolog B | 2 | 2 | ||||||||
MIRT444371 | CNBP | CCHC-type zinc finger nucleic acid binding protein | 2 | 2 | ||||||||
MIRT444517 | ZNF525 | zinc finger protein 525 | 2 | 2 | ||||||||
MIRT444525 | CNIH4 | cornichon family AMPA receptor auxiliary protein 4 | 2 | 2 | ||||||||
MIRT444529 | EIF2A | eukaryotic translation initiation factor 2A | 2 | 2 | ||||||||
MIRT444537 | PHKB | phosphorylase kinase regulatory subunit beta | 2 | 2 | ||||||||
MIRT444702 | GATSL2 | cytosolic arginine sensor for mTORC1 subunit 2 | 2 | 2 | ||||||||
MIRT444717 | CMSS1 | cms1 ribosomal small subunit homolog (yeast) | 2 | 2 | ||||||||
MIRT444730 | TMC7 | transmembrane channel like 7 | 2 | 2 | ||||||||
MIRT444777 | NAPEPLD | N-acyl phosphatidylethanolamine phospholipase D | 2 | 2 | ||||||||
MIRT444802 | TMEM251 | transmembrane protein 251 | 2 | 2 | ||||||||
MIRT444995 | LRRC57 | leucine rich repeat containing 57 | 2 | 2 | ||||||||
MIRT445073 | C16orf87 | chromosome 16 open reading frame 87 | 2 | 2 | ||||||||
MIRT445250 | SEMA5A | semaphorin 5A | 2 | 2 | ||||||||
MIRT445336 | KATNAL1 | katanin catalytic subunit A1 like 1 | 2 | 2 | ||||||||
MIRT445426 | TPT1 | tumor protein, translationally-controlled 1 | 2 | 4 | ||||||||
MIRT445469 | TRIM13 | tripartite motif containing 13 | 2 | 2 | ||||||||
MIRT445646 | NPY4R | neuropeptide Y receptor Y4 | 2 | 2 | ||||||||
MIRT445759 | AGO1 | argonaute 1, RISC catalytic component | 2 | 2 | ||||||||
MIRT445838 | SRSF11 | serine and arginine rich splicing factor 11 | 2 | 2 | ||||||||
MIRT445868 | ENTPD7 | ectonucleoside triphosphate diphosphohydrolase 7 | 2 | 2 | ||||||||
MIRT446368 | STX16 | syntaxin 16 | 2 | 2 | ||||||||
MIRT446444 | THYN1 | thymocyte nuclear protein 1 | 2 | 2 | ||||||||
MIRT446593 | TASP1 | taspase 1 | 2 | 2 | ||||||||
MIRT446926 | SRSF7 | serine and arginine rich splicing factor 7 | 2 | 2 | ||||||||
MIRT447121 | SLFN5 | schlafen family member 5 | 2 | 2 | ||||||||
MIRT447196 | CDCP1 | CUB domain containing protein 1 | 2 | 2 | ||||||||
MIRT447358 | STOM | stomatin | 2 | 2 | ||||||||
MIRT447361 | FAM161B | family with sequence similarity 161 member B | 2 | 2 | ||||||||
MIRT447374 | NUP205 | nucleoporin 205 | 2 | 2 | ||||||||
MIRT447467 | OSMR | oncostatin M receptor | 2 | 2 | ||||||||
MIRT447606 | MRPL3 | mitochondrial ribosomal protein L3 | 2 | 2 | ||||||||
MIRT447682 | ASPA | aspartoacylase | 2 | 2 | ||||||||
MIRT447715 | ERP44 | endoplasmic reticulum protein 44 | 2 | 2 | ||||||||
MIRT447814 | EMX1 | empty spiracles homeobox 1 | 2 | 2 | ||||||||
MIRT447855 | RRP8 | ribosomal RNA processing 8 | 2 | 4 | ||||||||
MIRT447866 | KIAA1244 | ARFGEF family member 3 | 1 | 1 | ||||||||
MIRT447890 | STRIP2 | striatin interacting protein 2 | 2 | 2 | ||||||||
MIRT447916 | PACSIN1 | protein kinase C and casein kinase substrate in neurons 1 | 2 | 2 | ||||||||
MIRT447935 | DUSP4 | dual specificity phosphatase 4 | 2 | 2 | ||||||||
MIRT448813 | GABRB1 | gamma-aminobutyric acid type A receptor beta1 subunit | 2 | 2 | ||||||||
MIRT448927 | CKS1B | CDC28 protein kinase regulatory subunit 1B | 2 | 2 | ||||||||
MIRT449105 | CREBRF | CREB3 regulatory factor | 2 | 2 | ||||||||
MIRT449216 | ZNHIT3 | zinc finger HIT-type containing 3 | 2 | 2 | ||||||||
MIRT449336 | ACTBL2 | actin, beta like 2 | 2 | 2 | ||||||||
MIRT449675 | SOX3 | SRY-box 3 | 2 | 2 | ||||||||
MIRT449724 | POU2F1 | POU class 2 homeobox 1 | 2 | 2 | ||||||||
MIRT449768 | PRAMEF7 | PRAME family member 7 | 2 | 2 | ||||||||
MIRT449804 | PRAMEF8 | PRAME family member 8 | 2 | 2 | ||||||||
MIRT449850 | BCL2L13 | BCL2 like 13 | 2 | 2 | ||||||||
MIRT449866 | POFUT2 | protein O-fucosyltransferase 2 | 2 | 2 | ||||||||
MIRT450067 | SYT9 | synaptotagmin 9 | 2 | 2 | ||||||||
MIRT450197 | ZHX3 | zinc fingers and homeoboxes 3 | 2 | 2 | ||||||||
MIRT450386 | TENM4 | teneurin transmembrane protein 4 | 2 | 2 | ||||||||
MIRT450435 | PAX8 | paired box 8 | 2 | 2 | ||||||||
MIRT450716 | PVRL3 | nectin cell adhesion molecule 3 | 2 | 2 | ||||||||
MIRT495906 | PGM2L1 | phosphoglucomutase 2 like 1 | 2 | 2 | ||||||||
MIRT497543 | PPTC7 | PTC7 protein phosphatase homolog | 2 | 2 | ||||||||
MIRT497630 | ZNF576 | zinc finger protein 576 | 2 | 2 | ||||||||
MIRT497756 | OXGR1 | oxoglutarate receptor 1 | 2 | 2 | ||||||||
MIRT498072 | SLC25A12 | solute carrier family 25 member 12 | 2 | 2 | ||||||||
MIRT500542 | XPO4 | exportin 4 | 2 | 4 | ||||||||
MIRT500848 | SYPL1 | synaptophysin like 1 | 2 | 4 | ||||||||
MIRT511621 | HIST1H3J | histone cluster 1 H3 family member j | 2 | 4 | ||||||||
MIRT513745 | PKNOX1 | PBX/knotted 1 homeobox 1 | 2 | 2 | ||||||||
MIRT535077 | PPP1CB | protein phosphatase 1 catalytic subunit beta | 2 | 2 | ||||||||
MIRT543133 | ZFP36L1 | ZFP36 ring finger protein like 1 | 2 | 2 | ||||||||
MIRT544518 | GTF2E2 | general transcription factor IIE subunit 2 | 2 | 2 | ||||||||
MIRT544666 | MED19 | mediator complex subunit 19 | 2 | 2 | ||||||||
MIRT545407 | KIAA1715 | lunapark, ER junction formation factor | 2 | 2 | ||||||||
MIRT547569 | LRIG3 | leucine rich repeats and immunoglobulin like domains 3 | 2 | 4 | ||||||||
MIRT548767 | CNN3 | calponin 3 | 2 | 2 | ||||||||
MIRT551009 | TRIM4 | tripartite motif containing 4 | 2 | 2 | ||||||||
MIRT555077 | PURG | purine rich element binding protein G | 2 | 2 | ||||||||
MIRT560753 | ZNF616 | zinc finger protein 616 | 2 | 2 | ||||||||
MIRT563752 | FOXO3 | forkhead box O3 | 2 | 2 | ||||||||
MIRT565531 | SON | SON DNA binding protein | 2 | 2 | ||||||||
MIRT613933 | HIVEP3 | human immunodeficiency virus type I enhancer binding protein 3 | 2 | 2 | ||||||||
MIRT614433 | TAZ | tafazzin | 2 | 2 | ||||||||
MIRT622520 | RAP2A | RAP2A, member of RAS oncogene family | 2 | 2 | ||||||||
MIRT626037 | AREL1 | apoptosis resistant E3 ubiquitin protein ligase 1 | 2 | 2 | ||||||||
MIRT648459 | LEAP2 | liver enriched antimicrobial peptide 2 | 2 | 2 | ||||||||
MIRT654982 | PLCXD3 | phosphatidylinositol specific phospholipase C X domain containing 3 | 2 | 4 | ||||||||
MIRT689103 | ZBTB25 | zinc finger and BTB domain containing 25 | 2 | 2 | ||||||||
MIRT704259 | DHCR24 | 24-dehydrocholesterol reductase | 2 | 2 | ||||||||
MIRT711194 | CXCL3 | C-X-C motif chemokine ligand 3 | 2 | 2 | ||||||||
MIRT713315 | VLDLR | very low density lipoprotein receptor | 2 | 2 | ||||||||
MIRT717266 | BMPR2 | bone morphogenetic protein receptor type 2 | 4 | 2 | ||||||||
MIRT718248 | CCDC18 | coiled-coil domain containing 18 | 2 | 2 | ||||||||
MIRT721944 | NGRN | neugrin, neurite outgrowth associated | 2 | 2 | ||||||||
MIRT721948 | IL1RAPL1 | interleukin 1 receptor accessory protein like 1 | 2 | 2 | ||||||||
MIRT734969 | PIK3R1 | phosphoinositide-3-kinase regulatory subunit 1 | 3 | 0 | ||||||||
MIRT735945 | NME2 | NME/NM23 nucleoside diphosphate kinase 2 | 0 | 0 | ||||||||
MIRT737404 | HOXA1 | homeobox A1 | 4 | 0 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|